| SARS-CoV-2 variant B. 1.1. 7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines X Shen, H Tang, C McDanal, K Wagh, W Fischer, J Theiler, H Yoon, D Li, ... Cell host & microbe 29 (4), 529-539. e3, 2021 | 445 | 2021 |
| Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G GBE Stewart-Jones, C Soto, T Lemmin, GY Chuang, A Druz, R Kong, ... Cell 165 (4), 813-826, 2016 | 444 | 2016 |
| Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies BF Haynes, K Wiehe, P Borrow, KO Saunders, B Korber, K Wagh, ... Nature Reviews Immunology 23 (3), 142-158, 2023 | 226 | 2023 |
| Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies M Bonsignori, EF Kreider, D Fera, RR Meyerhoff, T Bradley, K Wiehe, ... Science translational medicine 9 (381), eaai7514, 2017 | 206 | 2017 |
| Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C infection K Wagh, T Bhattacharya, C Williamson, A Robles, M Bayne, J Garrity, ... PLoS pathogens 12 (3), e1005520, 2016 | 206 | 2016 |
| Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, ... Cell 174 (4), 938-952. e13, 2018 | 205 | 2018 |
| HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design CA Bricault, K Yusim, MS Seaman, H Yoon, J Theiler, EE Giorgi, K Wagh, ... Cell host & microbe 25 (1), 59-72. e8, 2019 | 163 | 2019 |
| Potent and broad HIV-neutralizing antibodies in memory B cells and plasma LTD Williams, G Ofek, S Schätzle, JR McDaniel, X Lu, NI Nicely, L Wu, ... Science immunology 2 (7), eaal2200, 2017 | 155 | 2017 |
| Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes R Kong, MK Louder, K Wagh, RT Bailer, A deCamp, K Greene, H Gao, ... Journal of virology 89 (5), 2659-2671, 2015 | 149 | 2015 |
| Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail B Julg, PT Liu, K Wagh, WM Fischer, P Abbink, NB Mercado, JB Whitney, ... Science translational medicine 9 (408), eaao4235, 2017 | 138 | 2017 |
| Top production at the Tevatron/LHC and nonstandard, strongly interacting spin one particles D Choudhury, RM Godbole, RK Singh, K Wagh Physics Letters B 657 (1-3), 69-76, 2007 | 131 | 2007 |
| Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge B Julg, LJ Tartaglia, BF Keele, K Wagh, A Pegu, D Sok, P Abbink, ... Science translational medicine 9 (406), eaal1321, 2017 | 127 | 2017 |
| Completeness of HIV-1 envelope glycan shield at transmission determines neutralization breadth K Wagh, EF Kreider, Y Li, HJ Barbian, GH Learn, E Giorgi, PT Hraber, ... Cell reports 25 (4), 893-908. e7, 2018 | 108 | 2018 |
| Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization C Rademeyer, B Korber, MS Seaman, EE Giorgi, R Thebus, A Robles, ... PLoS pathogens 12 (7), e1005742, 2016 | 107 | 2016 |
| Vaccines and broadly neutralizing antibodies for HIV-1 prevention KE Stephenson, K Wagh, B Korber, DH Barouch Annual review of immunology 38 (1), 673-703, 2020 | 103 | 2020 |
| Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial B Julg, KE Stephenson, K Wagh, SC Tan, R Zash, S Walsh, J Ansel, ... Nature medicine 28 (6), 1288-1296, 2022 | 98 | 2022 |
| Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections K Wagh, MS Seaman, M Zingg, T Fitzsimons, DH Barouch, DR Burton, ... PLoS pathogens 14 (3), e1006860, 2018 | 92 | 2018 |
| Neutralization escape by SARS-CoV-2 Omicron subvariant BA. 2.86 N Lasrado, YC Ai-ris, NP Hachmann, J Miller, M Rowe, ED Schonberg, ... Vaccine 41 (47), 6904-6909, 2023 | 84 | 2023 |
| Lactase persistence and lipid pathway selection in the Maasai K Wagh, A Bhatia, G Alexe, A Reddy, V Ravikumar, M Seiler, M Boemo, ... Public Library of Science 7 (9), e44751, 2012 | 74 | 2012 |
| Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth RS Roark, H Li, WB Williams, H Chug, RD Mason, J Gorman, S Wang, ... Science 371 (6525), eabd2638, 2021 | 72 | 2021 |
Bette KorberLos Alamos National LaboratoryVerified email at lanl.gov